<p>Aspira Women’s Health Inc. 已与 Lincoln Park Capital Fund, LLC 签署了一份购买协议，根据该协议，Lincoln Park 承诺在公司的指示下，分期购买最多 1000 万美元的 Aspira 普通股。这些股票将作为未注册证券在私募中发行和出售，依赖于《证券法》第 4(a)(2) 条和 D 规则 506(b) 的注册豁免。与该协议相关，Aspira 还将向 SEC 提交注册声明，以覆盖 Lincoln Park 对这些股票的转售。Lincoln Park 是根据协议条款的合格投资者。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Aspira Women’s Health Inc. 于 2025 年 12 月 23 日通过美国证券交易委员会（Ref. ID: 0001104659-25-124245）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>

<p>Aspira Women's Health Inc. 已与 Lincoln Park Capital Fund, LLC 签署了一项 1000 万美元的私募协议。Lincoln Park 将逐步购买最多 1000 万美元的 Aspira 普通股。这些股票将作为未注册证券发行，Aspira 将向 SEC 提交注册声明以进行转售。根据协议，Lincoln Park 是一名合格投资者</p>

<p>Aspira Women’s Health Inc. has entered into a purchase agreement with Lincoln Park Capital Fund, LLC, under which Lincoln Park has committed to purchase up to $10 million of Aspira’s common stock at the company’s direction over time. The shares will be issued and sold in a private placement as unregistered securities, relying on exemptions from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D. In connection with the agreement, Aspira will also file a registration statement with the SEC to cover the resale of the shares by Lincoln Park. Lincoln Park is an accredited investor under the terms of the agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women’s Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124245), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>
<div class="lb-trans"><p>Aspira Women’s Health Inc. 已与 Lincoln Park Capital Fund, LLC 签署了一份购买协议，根据该协议，Lincoln Park 承诺在公司的指示下，分期购买最多 1000 万美元的 Aspira 普通股。这些股票将作为未注册证券在私募中发行和出售，依赖于《证券法》第 4(a)(2) 条和 D 规则 506(b) 的注册豁免。与该协议相关，Aspira 还将向 SEC 提交注册声明，以覆盖 Lincoln Park 对这些股票的转售。Lincoln Park 是根据协议条款的合格投资者。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Aspira Women’s Health Inc. 于 2025 年 12 月 23 日通过美国证券交易委员会（Ref. ID: 0001104659-25-124245）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>
</div>

Aspira Women's Health 宣布与 Lincoln Park Capital 达成 1000 万美元的私募融资协议